Sign inJoin waitlistJoin the waitlist

AS

Aparna Sahoo

Nephrology

Credentials: ·

History

Nephrology
2005–2007
Internal Medicine
2002–2005
Medical School
1998–2002

Research

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
The Lancet. Gastroenterology & hepatology · 2024 · 66 citations
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study
Gastroenterology · 2025 · 46 citations
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from…
The Lancet · 2025 · 37 citations

Bruce Sands
4 papers
NT
Natalie Terry
4 papers
MV
Marion Vetter
3 papers
Anita Afzali
2 papers
David Rubin
2 papers
GH
Gary Huang
1 paper
LS
Leonardo Salese
1 paper
MG
Matthew Germinaro
1 paper
MO
Mobolaji Olurinde
1 paper
TR
Timothy Ritter
1 paper
William Sandborn
1 paper